 (0,5, 1,0 et 
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2,0 Izg.kg-t.min-I). Chez cinq chiens, nous avons aussi mesurE I'effet de la perfusion du vEhicule de la nimodipine tt raison de I0 Ixl. kg -t . mbl -t sur le MAC. Avec 0,5, 1,0 et 2,0 tzg . kg-i. rain-i de nimodipine, le MAC de I' isoflurane passait de 1,47 +-0,33%4 1,19 +--0,18, 1,15 +--O,18et 1,15 +-0,09% respectivement. EmployE seul, le vEhicule de la nimodipine ne modifiait pas le MAC de l'isoflurane (I,39 +-O, 15%). Cette diminution des besoins en anesth~sique rEsulte peut-~tre des effets de la nimodipine sur la transmission nerveuse et il faudra sans doute en tenir compte en pratique.
Acute administration of calcium channel antagonists alters the effects of a variety of anaesthetic agents.' Verapamil, nitrendipine and flunarizine have all been reported to augment the anaesthetic potencies of ethanol, pentobarbital and argon in mice. Nitrendipine has been shown to alter nitrous oxide anaesthesia, tolerance and dependence. 2 Furthermore verapamil reduced the minimum alveolar concentration of halothane in dogs. 3 Nimodipine is a calcium channel antagonist with high affinity binding sites which are in close proximity to, or part of, membrane calcium channels. 4 It has recently gained popularity for the treatment of vasospasm associated with subarachnoid haemorrhage. 5 Furthermore, nimodipine has been shown to improve neurologic outcome following complete cerebral ischaemia in primates. 6 Since nimodipine is frequently administered to patients undergoing anaesthesia and surgery for intracranial aneurysms, this study was designed to determine if nimodipine alters the anaesthetic effect of isoflurane in dogs.
Methods
This study was approved by the Institutional Committee on Research Involving Animal Subjects. General anaesthesia was induced by inhalation of isoflurane 2-3% and oxygen via mask in II mongrel dogs of either sex, weighing 15-19 kg. Tracheal intubation was aCcomplished with a cuffed 8.0 mm endo-tracheal tube without the use of muscle relaxants. The dogs' lungs were then ventilated at a rate of ten breaths per minute. The tidal volume was adjusted to achieve an end-tidal carbon dioxide tension between 28 and 38 mmHg, as measured by infrared analysis (Siemens). Catheters were inserted into a femoral vein and artery and a continuous iv infusion of lactated Ringer's solution was begun a.t the rate of 4 ml.kg-~.hr -~. A heating pad was used to keep nasal temperature at 37.0 --0.5 ~ C. Temperature, ECG, arterial blood pressure and end-tidal carbon dioxide tension were continuously recorded, lsoflurane concentration was measured by infrared analysis with a Puritan Bennet Anesthetic Agent Monitor 222 (Wilmington, MA) The analyzer was calibrated for each study to the known concentration of calibration gas supplied by the manufacturer and to 0%. The instrument has a sensitivity of 0.1% and a maximum rise time of 600 msec. Exhaled gas was obtained from a 5~t inch 16-gauge Tefon catheter inserted through the endotracheal tube.
The MAC of isoflurane necessary to prevent purposeful movement in response to tail clamping was determined according to the method previously reported. 7 The base of the tail was shaved. After a stable end-tidal isoflurane concentration was maintained for at least 15 min, a clamp was applied to the base of the tail and closed to full ratchet lock for one minute or until purposeful movement was elicited. Following the determination of the response to the tail-clamp, the end-tidal isoflurane concentration was adjusted either up or down as appropriate, and response to tail-clamp was again determined. Purposeful movement was defined as gross movement of the head or extremities and did not include coughing, chewing, swallowing, or increased respiratory effort. The MAC was determined to be midway between the stable end-tidal concentrations of isoflurane (to the nearest 0. ! volume per cent) at which the animal did or did not move in response to the stimulus. Multiple tail-clamps were applied at multiple concentrations in each animal to determine MAC to the nearest 0.1%.
Following determination of the control MAC for isoflurane, six dogs received a continuous iv infusion of nimodipine at a rate of 0.5 p,g. kg-t. min-~. After 30 min of infusion MAC was again determined by the same technique. The MAC determinations were repeated after 30 min of nimodipine infusion given at an increased rate of 1.0 p,g.kg -~ .min -I and finally after 30 min of 2.0 p,g. kg-t. min-l infusion.
Five dogs received the drug vehicle alone, infused at a rate of 10 ~1. kg -~. min -I, which equals the volume of vehicle that was infused at the maximum nimodipine dose (2.0 p,g. kg -I ' min-I). After 30 min of vehicle infusion, MAC was again determined by the same method.
Both drug vehicle and nimodipine were provided by Miles Inc. (West Haven, CT). Solutions were diluted in 5% dextose solution prior to infusion. 
MAC (volume per cent)
Prior to nimodipine Nimodipine (0.5 p,g. kg-i. rain-~) Nimodipine ( 1.0 p,g. kg-~-rain-~) Nimodipine (2.0 p,g 'kg-i. min-i) Control values for MAC and mean arterial pressure (MAP), obtained before infusion of nimodipine, and at each drug infusion rate were compared by repeated measures one-way analysis of variance. Values for MAC and MAP before and after infusion of drug vehicle were compared by paired t test. P < 0.05 was considered statistically significant. Table I , the MAC of isoflurane decreased following the administration of nimodipine. There were no significant differences in the magnitude of MAC reduction among the three doses of drug. The mean reduction in MAC was 19.5% of the control value. Administration of drug vehicle, alone, resulted in no change in isoflurane MAC (Table 11 ). There were no differences in mean arterial pressure measured after each MAC determination (Table HI) .
Results

As shown in
Discussion
The neuronal effects of calcium antagonists appear to be mediated through slowly inactivating calcium ion channels (L-type) whose blockade leads to reduced intracellular entry of Ca + +.s Both neuronal and cerebrovasodilatory effects have been identified at nimodipine doses that produce no effect on peripheral circulation. 9-I i Nimodipine at 0.1-10 p,M concentrations has been shown to inhibit the release of radiolabelled acetylcholine from rat striatal and cerebral cortical slices. ~2 In the same preparation dopamine release was enhanced. However, in vivo, Pileblad and Carlsson reported that, in mice, nimodipine produced a dose-dependent decrease in the synthesis of brain dopamine and norepinephrine. 13'~4 Furthermore, nimodipine has also been shown to reduce the evoked release of norepinephrine in cultured rat neurons, is In the guinea pig ileum muscle strip preparation, a2-adrenoceptor blocking agents failed to enhance norepinephrine release in the presence of nimodipine. This suggests an a2-adrenoceptor blocking property of nimodipine. 16 The effect of nimodipine on endogenous opioids may The doses of nimodipine were chosen to be within the range administered clinically for the treatment of vasospasm following subarachnoid haemorrhage in man. ~8 These doses have also been shown to improve neurological outcome following cerebral ischaemia in animals. 6 The lack of a discrete dose-response relationship in the reduction of anaesthetic requirement by nimodipine probably reflects the relative insensitivity of MAC measurement in discriminating small changes in anaesthetic potency. This may also indicate a nonspecific, nonreceptor-mediated action of nimodipine on anaesthesia. Smaller doses of nimodipine would have been subclinical with expected reductions in MAC near the limit of sensitivity of this laboratory technique, t8 The absence of significant haemodynamic changes at these doses of calcium antagonist is in agreement with previous reports. 6. ~o
The finding that nimodipine reduces the MAC of isoflurane is in agreement with previous evidence of an interaction between calcium channel antagonists and anaesthetic agents. This effect would be particularly important in patients suffering from vasospasm undergoing intracranial aneurysm surgery, for whom anaesthetic dose must be carefully titrated to allow rapid emergence and timely evaluation of neurological function. The mechanism, however, by which inhibition of the influx of 241 extracellular calcium may augment the action of anaesthetics remains to be clarified.
